MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $114,532,000 | -3.2% | 1,393,000 | +72.7% | 2.38% | -4.9% |
| Q4 2021 | $118,291,000 | -37.1% | 806,400 | -24.1% | 2.51% | -39.7% |
| Q3 2021 | $187,949,000 | +54.5% | 1,062,400 | +41.1% | 4.16% | +26.7% |
| Q2 2021 | $121,632,000 | +49.3% | 753,000 | +58.3% | 3.29% | +46.0% |
| Q1 2021 | $81,487,000 | -2.4% | 475,700 | +25.2% | 2.25% | -16.9% |
| Q4 2020 | $83,463,000 | +82.8% | 380,000 | +38.2% | 2.71% | +28.0% |
| Q3 2020 | $45,664,000 | +101.4% | 275,000 | -6.8% | 2.12% | -32.4% |
| Q1 2020 | $22,677,000 | +175.0% | 295,000 | +360.9% | 3.13% | -39.7% |
| Q4 2019 | $8,247,000 | – | 64,000 | – | 5.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |